Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Senti Biosciences (SNTI) Leases (2021 - 2025)

Senti Biosciences has reported Leases over the past 5 years, most recently at $11.5 million for Q4 2025.

  • For Q4 2025, Leases fell 17.44% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $11.5 million, down 17.44%, while the annual FY2025 figure was $11.5 million, 17.44% down from the prior year.
  • Leases for Q4 2025 was $11.5 million at Senti Biosciences, down from $12.3 million in the prior quarter.
  • Over five years, Leases peaked at $20.7 million in Q4 2021 and troughed at $11.5 million in Q4 2025.
  • A 5-year average of $16.0 million and a median of $16.0 million in 2023 define the central range for Leases.
  • Biggest five-year swings in Leases: dropped 9.88% in 2023 and later decreased 17.44% in 2025.
  • Year by year, Leases stood at $20.7 million in 2021, then decreased by 11.06% to $18.4 million in 2022, then decreased by 11.64% to $16.3 million in 2023, then dropped by 14.29% to $13.9 million in 2024, then decreased by 17.44% to $11.5 million in 2025.
  • Business Quant data shows Leases for SNTI at $11.5 million in Q4 2025, $12.3 million in Q3 2025, and $12.8 million in Q2 2025.